Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Global Natural Killer Cell Therapy Competitive Landscape Professional Research Report 2024
... diseases, particularly cancer. NK cells are a type of white blood cell that plays a critical role in the body’s innate immune response, specifically targeting and eliminating abnormal or infected cells. In NK cell therapy, ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The single-use ... Read More
-
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Global Forecast to 2029
... & non-stem cell therapies market is projected to reach USD 22.2 billion by 2029 from USD 5.5 billion in 2024, at a CAGR of 32.3% during the forecast period. The growth of this market is ... Read More
-
3D Cell Culture Market Forecasts to 2030 - Global Analysis By Product (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting and Other Products), Application (Cancer Research, Stem Cell Research and Tissue Engineering, Drug Development and Toxicity Testing, Clinical Applications, Regenerative Medicine and Other Applications), End User and By Geography
... Testing, Clinical Applications, Regenerative Medicine and Other Applications), End User and By Geography According to Stratistics MRC, the Global 3D Cell Culture Market is accounted for $2.78 billion in 2024 and is expected to reach ... Read More
-
Global Stem Cell and Primary Cell Culture Medium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... Medium market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Stem Cells are a class ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030. Regenerative medicine is an interdisciplinary field that applies engineering and ... Read More
-
Biopreservation Market by Product (Biopreservation Media, Equipment, Lab Information Management Systems), Biospecimens (Cells, Microorganisms, Organs), Application, End-User - Global Forecast 2024-2030
... to reach USD 3.64 billion in 2024, at a CAGR 26.98% to reach USD 15.40 billion by 2030. Biopreservation is the process of preserving biological materials, such as cells, tissues, and organs, by stabilizing their ... Read More
-
3D Cell Culture Market by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture), Application (Cancer, Drug Discovery, Stem Cell Research), End-User - Global Forecast 2024-2030
... at USD 1.90 billion in 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 7.63% to reach USD 3.19 billion by 2030. 3D cell culture refers to the practice of growing ... Read More
-
Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-User - Global Forecast 2024-2030
... expected to reach USD 703.34 million in 2024, at a CAGR 19.94% to reach USD 2,124.91 million by 2030. Human organoids are 3-dimensional microscale in vitro tissue constructs that closely replicate human organs' architecture, functionality, ... Read More
-
Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Global Forecast 2024-2030
... Market size was estimated at USD 17.34 billion in 2023 and expected to reach USD 19.98 billion in 2024, at a CAGR 15.81% to reach USD 48.45 billion by 2030. Cell and gene therapy manufacturing ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Plasmid DNA, Viral Vector), Cell Line (In-vitro, In-Vivo), Transfection, Indication, Workflow, Application, End User - Global Forecast 2024-2030
... size was estimated at USD 1.50 billion in 2023 and expected to reach USD 1.88 billion in 2024, at a CAGR 25.34% to reach USD 7.32 billion by 2030. The market of viral vector and ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Microcarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide a surface ... Read More
-
Cancer Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Cancer Type, Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.72 billion in 2023 and expected to reach USD 5.21 billion in 2024, at a CAGR 10.55% to reach USD 9.54 billion by 2030. Cancer stem cells are cells found within tumors ... Read More
-
Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Global Forecast 2024-2030
... and expected to reach USD 9.60 billion in 2024, at a CAGR 10.93% to reach USD 17.91 billion by 2030. The cell therapy market encompasses the research, development, manufacturing, and commercialization of products and techniques ... Read More
-
Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.98 billion in 2024, at a CAGR 13.63% to reach USD 8.59 billion by 2030. Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into ... Read More
-
Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 15.05 billion in 2024, at a CAGR 10.79% to reach USD 27.99 billion by 2030. The stem cell market comprises various products and services used for the ... Read More
-
Organoids Global Market Opportunities And Strategies To 2033 Including: 1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids 2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine 3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations 4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells Covering: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
... from the COVID-19 shut down. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. • Understand how the market is being affected by ... Read More
-
Allogeneic Cell Therapy Market by Type (Chimeric Antigen Receptor T Cell Therapy, Hematopoietic Stem Cell Transplantation, Induced Pluripotent Stem Cell Therapy), Application (Hematological Disorders, Oncology, Regenerative Medicine), End-Use - Global Forecast 2024-2030
... Therapy Market size was estimated at USD 2.04 billion in 2023 and expected to reach USD 2.31 billion in 2024, at a CAGR 13.90% to reach USD 5.08 billion by 2030. Allogeneic cell therapy involves ... Read More
-
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Progenitor and Stem Cell Therapies), by Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), and by Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others)– Global Opportunity Analysis and Industry Forecast, 2024 – 2030
... Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others)– Global Opportunity Analysis and Industry Forecast, 2024 – 2030 The Regenerative Medicine Market size was valued at USD 24.85 billion in 2023, and is predicted to reach ... Read More
-
Global Viral Vector-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
... genetic disorders or diseases. These drugs typically contain modified viruses as vectors to efficiently and safely transfer genetic material into the cells of patients, aiming to correct genetic mutations or induce specific therapeutic effects. The ... Read More
-
Global Cord Blood Banking Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 46550 million in 2023 and is forecast to a readjusted size of USD 83970 million by 2030 with a CAGR of 8.8% during review period. According to our research, the global market for medical ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the CAR T-Cell Therapy for Multiple Myeloma, historical and forecasted epidemiology as well as the CAR T-Cell Therapy for Multiple Myeloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Limbal Stem Cells Deficiency (lsd) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Limbal Stem Cells Deficiency (lsd), historical and forecasted epidemiology as well as the Limbal Stem Cells Deficiency (lsd) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Cell and Gene Therapy Deals Analysis, 2021-2024
... in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the ... Read More
-
Allogeneic T-cell therapy for autoimmune diseases – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Allogeneic T-cell therapy for autoimmune diseases, historical and forecasted epidemiology as well as the Allogeneic T-cell therapy for autoimmune diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
Research Assistance
